000518 四环生物
已收盘 09-29 15:00:00
资讯
新帖
简况
四环生物（000518）9月28日主力资金净买入729.07万元
证券之星 · 09-28 15:30
四环生物（000518）9月28日主力资金净买入729.07万元
四环生物：第十一届董事会第五次会议决议公告
证券日报网 · 09-23
四环生物：第十一届董事会第五次会议决议公告
四环生物最新公告：拟1.6亿元收购长源药业80%股权
证券之星 · 09-23
四环生物最新公告：拟1.6亿元收购长源药业80%股权
股市必读：四环生物新发布《四环生物2026年第二次临时股东会法律意见书》
证券之星 · 09-23
股市必读：四环生物新发布《四环生物2026年第二次临时股东会法律意见书》
四环生物（000518）披露收购中润药业部分股权议案获临时股东大会通过，9月22日股价下跌2.33%
证券之星 · 09-22
四环生物（000518）披露收购中润药业部分股权议案获临时股东大会通过，9月22日股价下跌2.33%
四环生物：公司将于2026年9月21日召开2026年第二次临时股东会
证券日报网 · 09-04
四环生物：公司将于2026年9月21日召开2026年第二次临时股东会
四环生物最新公告：拟1.6亿元收购中润药业65.61%股权
证券之星 · 09-04
四环生物最新公告：拟1.6亿元收购中润药业65.61%股权
四环生物：截至2026年8月20日，公司股东人数为67353
证券之星 · 08-27
四环生物：截至2026年8月20日，公司股东人数为67353
股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%
证券之星 · 08-24
股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%
四环生物（000518）2026年中报简析：净利润同比下降155.8%
证券之星 · 08-22
四环生物（000518）2026年中报简析：净利润同比下降155.8%
四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%
证券之星 · 08-21
四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%
图解四环生物中报：第二季度单季净利润同比下降349.66%
证券之星 · 08-21
图解四环生物中报：第二季度单季净利润同比下降349.66%
四环生物（000518）披露2026年半年度报告，8月20日股价上涨0.27%
证券之星 · 08-20
四环生物（000518）披露2026年半年度报告，8月20日股价上涨0.27%
股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》
证券之星 · 08-19
股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》
股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》
证券之星 · 08-18
股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》
四环生物（000518）披露签订股权转让意向协议公告，8月17日股价上涨1.25%
证券之星 · 08-17
四环生物（000518）披露签订股权转让意向协议公告，8月17日股价上涨1.25%
四环生物最新公告：拟1.6亿元收购长源药业80%股权
证券之星 · 08-17
四环生物最新公告：拟1.6亿元收购长源药业80%股权
四环生物：截至2026年7月20日，公司股东人数为65060
证券之星 · 07-30
四环生物：截至2026年7月20日，公司股东人数为65060
四环生物（000518）披露2026年半年度业绩预告，7月13日股价下跌5.66%
证券之星 · 07-13
四环生物（000518）披露2026年半年度业绩预告，7月13日股价下跌5.66%
四环生物：预计2026年1-6月每股收益亏损:0.0204元至0.0291元
证券之星 · 07-10
四环生物：预计2026年1-6月每股收益亏损:0.0204元至0.0291元
加载更多
公司概况
公司名称：
江苏四环生物股份有限公司
所属行业：
医药制造业
上市日期：
1993-09-08
主营业务：
江苏四环生物股份有限公司的主营业务是生物医药制品的生产和销售；苗木的种植、销售及绿化工程业务。公司的主要产品是生物药品、处方药。
发行价格：
2.50
{"stockData":{"symbol":"000518","market":"SZ","secType":"STK","nameCN":"四环生物","latestPrice":3.59,"timestamp":1790665413000,"preClose":3.72,"halted":0,"volume":22889200,"delay":0,"changeRate":-0.0349,"floatShares":1030000000,"shares":1030000000,"eps":-0.0514,"marketStatus":"已收盘","change":-0.13,"latestTime":"09-29 15:00:00","open":3.69,"high":3.69,"low":3.59,"amount":82584100,"amplitude":0.0269,"askPrice":3.6,"askSize":2534,"bidPrice":3.59,"bidSize":7642,"shortable":0,"etf":0,"ttmEps":-0.0514,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790731800000},"marketStatusCode":5,"adr":0,"adjPreClose":3.72,"symbolType":"stock","openAndCloseTimeList":[[1790645400000,1790652600000],[1790658000000,1790665200000]],"highLimit":4.09,"lowLimit":3.35,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1029556222,"isCdr":false,"pbRate":12.4,"roa":"--","roe":"--","epsLYR":-0.036,"committee":0.548488,"marketValue":3696000000,"turnoverRate":0.0222,"status":1,"floatMarketCap":3696000000},"requestUrl":"/m/hq/s/000518","defaultTab":"news","newsList":[{"id":"2670928287","title":"四环生物（000518）9月28日主力资金净买入729.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670928287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670928287?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:30","pubTimestamp":1790580627,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，四环生物报收于3.72元，上涨1.36%，换手率2.52%，成交量25.96万手，成交额9751.44万元。9月28日的资金流向数据方面，主力资金净流入729.07万元，占总成交额7.48%，游资资金净流入80.14万元，占总成交额0.82%，散户资金净流出809.2万元，占总成交额8.3%。四环生物主营业务：主要从事生物医药制品的生产和销售以及园林绿化工程业务。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","BK0145","000518","BK0046","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148464","title":"四环生物：第十一届董事会第五次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148464","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148464?lang=zh_cn&edition=full","pubTime":"2026-09-23 21:32","pubTimestamp":1790170320,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月23日，四环生物（维权）发布公告称，公司于2026年9月23日召开第十一届董事会第五次会议，本次会议审议通过《关于收购吉林省长源药业有限公司部分股权的议案》等多项议案。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-23/doc-inisvqcz1106664.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-23/doc-inisvqcz1106664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0239","BK0086","BK0145","BK0168","000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669003291","title":"四环生物最新公告：拟1.6亿元收购长源药业80%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2669003291","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669003291?lang=zh_cn&edition=full","pubTime":"2026-09-23 18:50","pubTimestamp":1790160652,"startTime":"0","endTime":"0","summary":"四环生物(000518.SZ)公告称，公司拟以现金方式收购吉林省长源药业有限公司80%股权，交易价格为1.6亿元。本次交易完成后，长源药业将成为公司控股子公司。标的公司主要产品包括琥珀酰明胶注射液、脑栓康复胶囊等。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300034355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","000518","BK0145","BK0239","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669614121","title":"股市必读：四环生物新发布《四环生物2026年第二次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669614121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669614121?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:30","pubTimestamp":1790101833,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年第二次临时股东会审议通过《关于收购中润药业有限公司部分股权的议案》，同意比例达99.6654%，已获三分之二以上通过。公司公告汇总四环生物2026年第二次临时股东会法律意见书江苏四环生物股份有限公司于2026年9月21日召开2026年第二次临时股东会，会议由董事会召集，采用现场与网络投票相结合方式举行。江苏世纪同仁律师事务所对本次会议出具了法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0145","BK0046","BK0239","BK0086","000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148745","title":"四环生物（000518）披露收购中润药业部分股权议案获临时股东大会通过，9月22日股价下跌2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148745","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148745?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:46","pubTimestamp":1790070388,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，四环生物报收于3.78元，较前一交易日下跌2.33%，最新总市值为38.92亿元。公司于近日披露《江苏四环生物股份有限公司2026年第二次临时股东会决议公告》。公告显示，江苏四环生物股份有限公司于2026年9月21日召开2026年第二次临时股东会，会议采用现场与网络投票相结合方式召开，出席股东及代理人共397名，代表有表决权股份375,446,635股，占公司股本总额的36.4668%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200031317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0145","BK0086","000518","BK0046","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664370263","title":"四环生物：公司将于2026年9月21日召开2026年第二次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2664370263","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664370263?lang=zh_cn&edition=full","pubTime":"2026-09-04 21:22","pubTimestamp":1788528120,"startTime":"0","endTime":"0","summary":"证券日报网讯9月4日，四环生物（维权）发布公告称，公司将于2026年9月21日召开2026年第二次临时股东会。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-04/doc-iniqsran0812294.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-04/doc-iniqsran0812294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0168","000518","BK0086","BK0145","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664104336","title":"四环生物最新公告：拟1.6亿元收购中润药业65.61%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2664104336","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664104336?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:49","pubTimestamp":1788518983,"startTime":"0","endTime":"0","summary":"四环生物(000518.SZ)公告称，公司拟以现金1.6亿元收购中润药业65.6146%股权，交易完成后中润药业将成为控股子公司。同时，中润药业将向定向减资方定向减少17.9817%股权，不支付减资对价，减资完成后公司将持有其80%股权。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400035418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","000518","BK0168","BK0086","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700693","title":"四环生物：截至2026年8月20日，公司股东人数为67353","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662700693?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:51","pubTimestamp":1787835087,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物(000518)08月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问8月20日股东人数是多少？谢谢四环生物回复：投资者您好，截至2026年8月20日，公司股东人数为67353。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700051293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518","BK0168","BK0239","BK0086","BK0145","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661061243","title":"股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661061243","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661061243?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:25","pubTimestamp":1787505912,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第二季度单季度归母净利润为-1451.94万元，同比下降349.66%。业绩披露要点财务报告2026年中报显示，上半年度公司主营收入1.11亿元，同比下降39.12%；归母净利润-2583.32万元，同比下降155.8%；扣非净利润-2817.44万元，同比下降135.59%；其中2026年第二季度单季度主营收入2957.22万元，同比下降78.58%；单季度归母净利润-1451.94万元，同比下降349.66%；单季度扣非净利润-1446.16万元，同比下降318.89%；负债率28.0%，投资收益0.0万元，财务费用49.65万元，毛利率20.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661388218","title":"四环生物（000518）2026年中报简析：净利润同比下降155.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661388218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661388218?lang=zh_cn&edition=full","pubTime":"2026-08-22 06:08","pubTimestamp":1787350082,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期四环生物发布2026年中报。根据财报显示，四环生物净利润同比下降155.8%。截至本报告期末，公司营业总收入1.11亿元，同比下降39.12%，归母净利润-2583.32万元，同比下降155.8%。按单季度数据看，第二季度营业总收入2957.22万元，同比下降78.58%，第二季度归母净利润-1451.94万元，同比下降349.66%。投资活动产生的现金流量净额变动幅度为-310.85%,原因:报告期因处置子公司收到的现金同比减少。本文数据来源于四环生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200004902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661269416","title":"四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661269416","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661269416?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:40","pubTimestamp":1787305247,"startTime":"0","endTime":"0","summary":"证券之星消息，近日四环生物披露，截至2026年8月10日公司股东户数为6.53万户，较7月31日增加1186.0户，增幅为1.85%。在生物制品行业个股中，四环生物股东户数高于行业平均水平，截至8月10日，生物制品行业平均股东户数为3.53万户。从股价来看，2026年7月31日至2026年8月10日，四环生物区间涨幅为14.4%，在此期间股东户数增加1186.0户，增幅为1.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0145","BK0086","BK0168","000518","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661393772","title":"图解四环生物中报：第二季度单季净利润同比下降349.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661393772","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661393772?lang=zh_cn&edition=full","pubTime":"2026-08-21 01:23","pubTimestamp":1787246601,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物2026年中报显示，上半年度公司主营收入1.11亿元，同比下降39.12%；归母净利润-2583.32万元，同比下降155.8%；扣非净利润-2817.44万元，同比下降135.59%；其中2026年第二季度，公司单季度主营收入2957.22万元，同比下降78.58%；单季度归母净利润-1451.94万元，同比下降349.66%；单季度扣非净利润-1446.16万元，同比下降318.89%；负债率28.0%，投资收益0.0万元，财务费用49.65万元，毛利率20.57%。财报数据概要请见下图:本文数据来源于四环生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100001168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660383612","title":"四环生物（000518）披露2026年半年度报告，8月20日股价上涨0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660383612","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660383612?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:19","pubTimestamp":1787235554,"startTime":"0","endTime":"0","summary":"近日，江苏四环生物股份有限公司披露2026年半年度报告摘要显示，本报告期营业收入为110,742,539.50元，较上年同期的181,897,153.17元下降39.12%；归属于上市公司股东的净利润为-25,833,217.42元，较上年同期的-10,098,947.40元下降155.80%；扣除非经常性损益后的净利润为-28,174,380.60元，同比下降135.59%。本报告期末总资产为459,607,382.97元，较上年度末的494,042,669.78元下降6.97%；归属于上市公司股东的净资产为308,787,797.89元，较上年度末减少7.72%。公司控股股东和实际控制人在报告期内未发生变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518","BK0145","BK0239","BK0046","BK0168","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660995694","title":"股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660995694","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660995694?lang=zh_cn&edition=full","pubTime":"2026-08-19 01:10","pubTimestamp":1787073018,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏四环生物股份有限公司第十一届董事会第二次会议决议公告江苏四环生物股份有限公司于2026年8月17日召开第十一届董事会第二次会议，审议通过公司拟与江西济鑫生物科技有限公司签订《股权转让意向协议》，以现金方式收购其持有的吉林省长源药业有限公司80%股权，暂定转让价格为1.6亿元人民币。本次交易不构成关联交易，预计不构成重大资产重组。公司已召开董事会审议通过签订意向协议的议案，并授权管理层推进相关工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","000518","BK0046","BK0168","BK0239","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439051","title":"股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439051","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660439051?lang=zh_cn&edition=full","pubTime":"2026-08-18 01:01","pubTimestamp":1786986074,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏四环生物股份有限公司第十一届董事会第二次会议决议公告江苏四环生物股份有限公司于2026年8月17日召开第十一届董事会第二次会议，审议通过公司拟与江西济鑫生物科技有限公司签订《股权转让意向协议》，以现金方式收购其持有的吉林省长源药业有限公司80%股权，暂定转让价格为1.6亿元人民币。本次交易不构成关联交易，预计不构成重大资产重组。公司已召开董事会审议通过签订意向协议的议案，并授权管理层推进相关工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800001356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0168","BK0046","BK0239","BK0145","000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660743586","title":"四环生物（000518）披露签订股权转让意向协议公告，8月17日股价上涨1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660743586","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660743586?lang=zh_cn&edition=full","pubTime":"2026-08-17 22:14","pubTimestamp":1786976080,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘，四环生物报收于4.06元，较前一交易日上涨1.25%，最新总市值为41.8亿元。该股当日开盘4.01元，最高4.16元，最低3.92元，成交额达2.26亿元，换手率为5.45%。近日，江苏四环生物股份有限公司发布《关于签订股权转让意向协议的公告》。公告显示，公司拟以现金方式收购吉林省长源药业有限公司80%的股权，暂定转让价格为1.6亿元人民币。公司已召开董事会审议通过签订意向协议的议案，并授权管理层推进相关工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700035193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518","BK0145","BK0239","BK0046","BK0168","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484671","title":"四环生物最新公告：拟1.6亿元收购长源药业80%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484671","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660484671?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:00","pubTimestamp":1786964426,"startTime":"0","endTime":"0","summary":"四环生物(000518.SZ)公告称，公司拟以现金方式收购吉林长源药业80%股权，交易对价1.6亿元。标的公司主营药品生产销售，核心产品为琥珀酰明胶注射液。本次交易尚处筹划阶段，最终能否达成存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700027745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0046","000518","BK0086","BK0145","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655870951","title":"四环生物：截至2026年7月20日，公司股东人数为65060","url":"https://stock-news.laohu8.com/highlight/detail?id=2655870951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655870951?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:51","pubTimestamp":1785415874,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物(000518)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止7月20日公司股东数？四环生物回复：投资者您好，截至2026年7月20日，公司股东人数为65060。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000037323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518","BK0046","BK0168","BK0239","BK0086","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651266190","title":"四环生物（000518）披露2026年半年度业绩预告，7月13日股价下跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651266190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651266190?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:46","pubTimestamp":1783936008,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，四环生物报收于3.83元，较前一交易日下跌5.66%，最新总市值为39.43亿元。该股当日开盘4.01元，最高4.05元，最低3.8元，成交额达3.96亿元，换手率为9.9%。近日，公司披露《江苏四环生物股份有限公司2026年半年度业绩预告》。业绩亏损主要因控股子公司北京四环生物制药有限公司受药品集中带量采购政策影响，主要产品售价下滑，营业收入下降，亏损增加。本次业绩预告未经审计，最终数据以2026年半年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300026597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","BK0168","BK0046","BK0086","000518","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650187299","title":"四环生物：预计2026年1-6月每股收益亏损:0.0204元至0.0291元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650187299","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650187299?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:01","pubTimestamp":1783684918,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物发布业绩预告，预计2026年1-6月每股收益亏损:0.0204元至0.0291元。四环生物2026年一季报显示，一季度公司主营收入8117.03万元，同比上升85.14%；归母净利润-1131.38万元，同比上升28.91%；扣非净利润-1371.28万元，同比上升26.14%；负债率27.57%，投资收益0.0万元，财务费用42.78万元，毛利率19.13%。本文数据来源于《四环生物:江苏四环生物股份有限公司2026年半年度业绩预告》，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000039797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0145","BK0086","BK0168","000518"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790718211895,"stockEarnings":[{"period":"1week","weight":-0.0503},{"period":"1month","weight":-0.0747},{"period":"3month","weight":0.0621},{"period":"6month","weight":0.2379},{"period":"1year","weight":0.5746},{"period":"ytd","weight":0.4896}],"compareEarnings":[{"period":"1week","weight":-0.0308},{"period":"1month","weight":-0.0308},{"period":"3month","weight":-0.0686},{"period":"6month","weight":-0.0227},{"period":"1year","weight":-0.0083},{"period":"ytd","weight":-0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏四环生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"62142人(较上一季度减少7.74%)","perCapita":"16567股","listingDate":"1993-09-08","address":"江苏省无锡市江阴市滨江东路2号41楼05、06座","registeredCapital":"102955万元","survey":" 江苏四环生物股份有限公司的主营业务是生物医药制品的生产和销售；苗木的种植、销售及绿化工程业务。公司的主要产品是生物药品、处方药。","listedPrice":2.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"四环生物(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供四环生物(000518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"四环生物,000518,四环生物股票,四环生物股票老虎,四环生物股票老虎国际,四环生物行情,四环生物股票行情,四环生物股价,四环生物股市,四环生物股票价格,四环生物股票交易,四环生物股票购买,四环生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"四环生物(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供四环生物(000518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}